Hydroxychloroquine in Mild Graves' Orbitopathy

Recruiting now · Phase 4

Conditions studied: Graves Ophthalmopathy

In brief

This study is aimed to investigate the effect of hydroxychloroquine in patients with mild Graves' orbitopathy (GO).

Key facts

Study ID
NCT05126147
Run by
National Taiwan University Hospital
People needed
108
Starts
2022-03-21
Expected to finish
2026-12-31
Last updated by the study team
2025-02-25

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.